Podcasts

Glutamatergic therapies

Author and Disclosure Information

Kristen Wiese, PharmD, discusses the long-term efficacy of glutamatergic therapies for depression.


 

Recommended Reading

Vitamin D landscape marked by lack of consensus
MDedge Psychiatry
Teen delinquency, substance use linked to maternal depression
MDedge Psychiatry
New insights into relationship between alcohol, depression, and suicide
MDedge Psychiatry
Higher opioid doses associated with increase in depression
MDedge Psychiatry
Medicine grapples with physician suicide
MDedge Psychiatry
Psychiatric diagnoses rank first and third among Medicaid admissions
MDedge Psychiatry
Do glutamatergic drugs have a role in treating depression?
MDedge Psychiatry
Prescriber’s guide to using 3 new antidepressants: Vilazodone, levomilnacipran, vortioxetine
MDedge Psychiatry
Can social media help mental health practitioners prevent suicides?
MDedge Psychiatry
‘No SAD Me’: A memory device for treating bipolar depression with an antidepressant
MDedge Psychiatry

Related Articles